Patents by Inventor Tom Miller

Tom Miller has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11407666
    Abstract: Per- and polyfluoroalkyl substances (PFAS) are destroyed by oxidation in supercritical conditions. PFAS in water is concentrated in a reverse osmosis step and salt from the resulting solution is removed in supercritical conditions prior to destruction of PFAS in supercritical conditions.
    Type: Grant
    Filed: August 6, 2021
    Date of Patent: August 9, 2022
    Assignee: Battelle Memorial Institute
    Inventors: Stephen H. Rosansky, Michael Miller, Patrick Norris, Darwin Argumedo, Douglas Hendry, Ian Haggerty, Keith Brown, Joshua James, Joseph Casciano, Slawomir Winecki, Vivek Lal, Tom McGuinness
  • Publication number: 20220218358
    Abstract: An embolization microcatheter for delivery of embolization beads to a target area, the microcatheter including a proximal end and a distal end, the distal end terminating in an end opening sized and shaped to allow delivery of a suspension of embolization beads, and a filter section located between in proximity to the distal end opening; the filter section including a large plurality of openings distributed circumferentially around a wall thereof, the filter section configured to allow outflow of the suspension fluid while preventing outflow of the embolization beads.
    Type: Application
    Filed: May 27, 2020
    Publication date: July 14, 2022
    Inventors: Tom DAGAN, Nir HOLTZMAN, Yuval ZIPORY, Osnat HARBATER, Eran MILLER
  • Patent number: 11382639
    Abstract: A medical drive unit receives and rotationally drives a medical, preferably surgical tool, by a motor, preferably an electric motor, housed in the drive unit which can be operated via a control or regulation unit. The medical drive unit includes a sensor device for directly or indirectly detecting or determining a movement of the drive unit or a holding movement of the user which is triggered by the motor corresponding to the power applied to the tool and a kickback control which automatically effects a reduction of the driving power or turning off of the motor upon detection of a predetermined drive unit or holding movement or a predetermined drive-unit or holding-movement amount.
    Type: Grant
    Filed: August 4, 2020
    Date of Patent: July 12, 2022
    Assignee: AESCULAP AG
    Inventors: Simon Miller, Robin Andris, Tom Fesenmeyer
  • Publication number: 20220157201
    Abstract: A label including a first strip including a first end and a second end opposite the first end. The first strip includes an opaque material. The first strip further includes a first area proximate the first end. The first area includes a first length along a longitudinal axis common to the first strip. The label also includes a second strip including a third end and a fourth end opposite the third end, wherein the second strip includes a transparent material. The second strip is laminated over the first strip such that the third end is disposed outside the first area. The fourth end extends beyond the second end a distance at least equal to the first length.
    Type: Application
    Filed: November 13, 2020
    Publication date: May 19, 2022
    Applicant: Platinum Press, Inc.
    Inventor: Tom Miller
  • Patent number: 11325337
    Abstract: A method of folding a sheet of paper. The method includes: folding the sheet of paper into an accordion shape comprising a plurality of pleats and collapsing the pleats to form a strip; folding the strip about in half to form a first folded strip; folding the first folded strip about a point that is about two-thirds a length of the first folded strip to form a second folded strip comprising an exposed portion that is about a third the length of the first folded strip; and folding the second folded strip about in half to form a third folded strip.
    Type: Grant
    Filed: September 14, 2018
    Date of Patent: May 10, 2022
    Assignee: Platinum Press, Inc.
    Inventors: Ruben Luviano, Tom Miller
  • Patent number: 11278244
    Abstract: Systems and methods are provided for detecting changes or fluctuations in an analyte concentration signal that are abnormal, e.g., exceed a predetermined threshold, current trend of analyte concentration measurements, etc. Signals indicative of an analyte concentration in a host may be received from an analyte sensor. The signals may be monitored, and a determination can be made as to whether there is a change in the signal. Upon detecting such a change, the change can be compensated for such that a representation of the signal indicates the analyte concentration. Optionally, the cause of the detected changes or fluctuations can also be determined and information regarding the detected changes or fluctuations can be recorded and analyzed for subsequent optimization of the systems and methods as well for transmitting alerts, notifications, etc. to a user to take corrective action.
    Type: Grant
    Filed: March 17, 2017
    Date of Patent: March 22, 2022
    Assignee: Dexcom, Inc.
    Inventors: Douglas William Burnette, Hari Hampapuram, Apurv Ullas Kamath, Shawn Larvenz, Aditya Mandapaka, Zebediah L. McDaniel, Tom Miller, Jeffrey R. Wedekind, Yonghuang Zeng, Stephen Alan Reichert
  • Patent number: 11179069
    Abstract: The present invention relates generally to systems and methods for processing, transmitting, and displaying data received from continuous analyte sensor, such as a glucose sensor. In some embodiments, the continuous analyte sensor system comprises a sensor electronics module that includes power saving features. One feature includes a low power measurement circuit that can be switched between a measurement mode and a low power mode, in which charging circuitry continues to apply power to electrodes of a sensor during the low power mode. In addition, the sensor electronics module can be switched between in a low power storage mode higher power operational mode via a switch. The switch can include a reed switch or optical switch, for example. A validation routine can also be implemented to ensure an interrupt signal sent from the switch is valid.
    Type: Grant
    Filed: July 30, 2019
    Date of Patent: November 23, 2021
    Assignee: DexCom, Inc.
    Inventors: Sebastian Bohm, Mark Dervaes, Eric Johnson, Apurv Ullas Kamath, Shawn Larvenz, Jacob S. Leach, Phong Lieu, Aarthi Mahalingam, Tom Miller, Paul V. Neale, Jack Pryor, Thomas A. Peyser, Daiting Rong, Kenneth San Vicente, Mohammad Ali Shariati, Peter C. Simpson, Matthew Wightlin
  • Publication number: 20210331439
    Abstract: A method of folding a sheet of paper. The method includes: folding the sheet of paper into an accordion shape comprising a plurality of pleats and collapsing the pleats to form a strip; folding the strip about in half to form a first folded strip; folding the first folded strip about a point that is about two-thirds a length of the first folded strip to form a second folded strip comprising an exposed portion that is about a third the length of the first folded strip; and folding the second folded strip about in half to form a third folded strip.
    Type: Application
    Filed: September 14, 2018
    Publication date: October 28, 2021
    Inventors: Ruben Luviano, Tom Miller
  • Publication number: 20210306692
    Abstract: A set top/back box and system and method for providing a remote control device are disclosed. In one embodiment, one or more wireless transceivers are located within a housing, which also interconnectively includes television input/output, a processor, and memory. The set top/back box may establish a pairing with a programmable device, such as a proximate wireless-enabled interactive handheld device having a touch screen display, whereby formatted parallel audiovisual experience instructions, including virtual buttons, may be transmitted to the programmable device for display on the touch screen display to create an experience parallel to the experience on the television. The set top/back box receives and processes virtual remote control functionality input instructions from the programmable device to control amenities associated with the set top/back box.
    Type: Application
    Filed: June 14, 2021
    Publication date: September 30, 2021
    Inventors: Vanessa Ogle, Bill Fang, Tom Miller, Scott Horton
  • Publication number: 20210251531
    Abstract: The present invention relates generally to systems and methods for processing, transmitting, and displaying data received from continuous analyte sensor, such as a glucose sensor. In some embodiments, the continuous analyte sensor system comprises a sensor electronics module that includes power saving features. One feature includes a low power measurement circuit that can be switched between a measurement mode and a low power mode, in which charging circuitry continues to apply power to electrodes of a sensor during the low power mode. In addition, the sensor electronics module can be switched between in a low power storage mode higher power operational mode via a switch. The switch can include a reed switch or optical switch, for example. A validation routine can also be implemented to ensure an interrupt signal sent from the switch is valid.
    Type: Application
    Filed: April 22, 2021
    Publication date: August 19, 2021
    Inventors: Sebastian Bohm, Mark Dervaes, Eric Johnson, Apurv Ullas Kamath, Shawn Larvenz, Jacob S. Leach, Phong Lieu, Aarthi Mahalingam, Tom Miller, Paul V. Neale, Jack Pryor, Thomas A. Peyser, Daiting Rong, Kenneth San Vicente, Mohammad Ali Shariati, Peter C. Simpson, Matthew Wightlin
  • Patent number: 11040957
    Abstract: The present invention provides novel compounds of Formula (I), and pharmaceutically acceptable salts, solvates, hydrates, tautomers, stereoisomers, isotopically labeled derivatives, and compositions thereof. Also provided are methods and kits involving the compounds or compositions for treating or preventing proliferative diseases (e.g., cancers (e.g., leukemia, melanoma, multiple myeloma), benign neoplasms, angiogenesis, inflammatory diseases, autoinflammatory diseases, and autoimmune diseases) in a subject. Treatment of a subject with a proliferative disease using a compound or composition of the invention may inhibit the aberrant activity of a kinase, such as a cyclin-dependent kinase (CDK) (e.g., cyclin-dependent kinase 7 (CDK7)), and therefore, induce cellular apoptosis and/or inhibit transcription in the subject.
    Type: Grant
    Filed: December 5, 2018
    Date of Patent: June 22, 2021
    Assignees: Dana-Farber Cancer Institute, Inc., Syros Pharmaceuticals, Inc.
    Inventors: Stephane Ciblat, Patrick Deroy, Nathanael Gray, Melissa Leblanc, Jason J. Marineau, Joel Moore, Kevin Sprott, Tinghu Zhang, M. Arshad Siddiqui, Anzhelika Kabro, Serge Leger, Stephanie Roy, Darby Schmidt, Dana K. Winter, Michael Bradley, Tom Miller
  • Patent number: 11039197
    Abstract: A set top/back box and system and method for providing a remote control device are disclosed. In one embodiment, one or more wireless transceivers are located within a housing, which also interconnectivley includes television input/output, a processor, and memory. The set top/back box may establish a pairing with a programmable device, such as a proximate wireless-enabled interactive handheld device having a touch screen display, whereby formatted parallel audiovisual experience instructions, including virtual buttons, may be transmitted to the programmable device for display on the touch screen display to create an experience parallel to the experience on the television. The set top/back box receives and processes virtual remote control functionality input instructions from the programmable device to control amenities associated with the set top/back box.
    Type: Grant
    Filed: November 19, 2018
    Date of Patent: June 15, 2021
    Assignee: Enseo, LLC
    Inventors: Vanessa Ogle, Bill Fang, Tom Miller, Scott Horton
  • Patent number: 11008071
    Abstract: A rotary chain jack may include a frame, a dual chain wheel rotatably coupled to the frame, and a stopper assembly mechanically coupled to the frame. The stopper assembly may include latches. The stopper assembly may be positioned to selectively engage a chain passing over the dual chain wheel. The rotary chain jack may be used to moor offshore structures.
    Type: Grant
    Filed: February 13, 2017
    Date of Patent: May 18, 2021
    Assignee: Bardex Corporation
    Inventors: Charlie O'Rourke, Tom Miller, Nick Atallah, Matt Frowiss, Kanghua Sun
  • Publication number: 20210061803
    Abstract: The present invention provides novel compounds of Formula (I) and pharmaceutically acceptable salts, solvates, hydrates, tautomers, stereoisomers, isotopically labeled derivatives, and compositions thereof. Also provided are methods and kits involving the compounds or compositions for treating or preventing proliferative diseases (e.g., cancers (e.g., leukemia, melanoma, multiple myeloma), benign neoplasms, angiogenesis, inflammatory diseases, autoinflammatory diseases, and autoimmune diseases) in a subject. Treatment of a subject with a proliferative disease using a compound or composition of the invention may inhibit the aberrant activity of cyclin-dependent kinase (e.g., CDK7), and therefore induce cellular apoptosis and/or inhibit transcription in the subject.
    Type: Application
    Filed: November 13, 2020
    Publication date: March 4, 2021
    Inventors: Stephane Ciblat, Anzhelika Kabro, Melissa Leblanc, Serge Leger, Jason J. Marineau, Tom Miller, Stephanie Roy, Darby Schmidt, M. Arshad Siddiqui, Kevin Sprott, Dana K. Winter, Amy Ripka, Dansu Li, Guoli Zhang
  • Patent number: 10906889
    Abstract: The present invention provides novel compounds of Formula (I), and pharmaceutically acceptable salts, solvates, hydrates, polymorphs, co-crystals, tautomers, stereoisomers, isotopically labeled derivatives, prodrugs, and compositions thereof. Also provided are methods and kits involving the inventive compounds or compositions for treating or preventing proliferative diseases (e.g., cancers (e.g., leukemia, lymphoma, melanoma, multiple myeloma, breast cancer, Ewing's sarcoma, osteosarcoma, brain cancer, neuroblastoma, lung cancer), benign neoplasms, angiogenesis, inflammatory diseases, autoinflammatory diseases, and autoimmune diseases) in a subject. Treatment of a subject with a proliferative disease using a compound or composition of the invention may inhibit the aberrant activity of a kinase, such as a cyclin-dependent kinase (CDK) (e.g.
    Type: Grant
    Filed: August 1, 2018
    Date of Patent: February 2, 2021
    Assignee: Dana-Farber Cancer Institute, Inc.
    Inventors: Nathanael Gray, Tinghu Zhang, Stephane Ciblat, Melissa Leblanc, Jason J. Marineau, Joel Moore, Kevin Sprott, M. Arshad Siddiqui, Anzhelika Kabro, Tom Miller, Stephanie Roy, Darby Schmidt, Dana K. Winter, Michael Bradley
  • Patent number: 10865206
    Abstract: The present invention provides novel compounds of Formula (I) and pharmaceutically acceptable salts, solvates, hydrates, tautomers, stereoisomers, isotopically labeled derivatives, and compositions thereof. Also provided are methods and kits involving the compounds or compositions for treating or preventing proliferative diseases (e.g., cancers (e.g., leukemia, melanoma, multiple myeloma), benign neoplasms, angiogenesis, inflammatory diseases, autoinflammatory diseases, and autoimmune diseases) in a subject. Treatment of a subject with a proliferative disease using a compound or composition of the invention may inhibit the aberrant activity of cyclin-dependent kinase (e.g., CDK7), and therefore induce cellular apoptosis and/or inhibit transcription in the subject.
    Type: Grant
    Filed: May 15, 2019
    Date of Patent: December 15, 2020
    Assignee: Syros Pharmaceuticals, Inc.
    Inventors: Stephane Ciblat, Anzhelika Kabro, Melissa Leblanc, Serge Leger, Jason J. Marineau, Tom Miller, Stephanie Roy, Darby Schmidt, M. Arshad Siddiqui, Kevin Sprott, Dana K. Winter, Amy Ripka, Dansu Li, Guoli Zhang
  • Publication number: 20200275894
    Abstract: Systems and methods are provided for detecting changes or fluctuations in an analyte concentration signal that are abnormal, e.g., exceed a predetermined threshold, current trend of analyte concentration measurements, etc. Signals indicative of an analyte concentration in a host may be received from an analyte sensor. The signals may be monitored, and a determination can be made as to whether there is a change in the signal. Upon detecting such a change, the change can be compensated for such that a representation of the signal indicates the analyte concentration. Optionally, the cause of the detected changes or fluctuations can also be determined and information regarding the detected changes or fluctuations can be recorded and analyzed for subsequent optimization of the systems and methods as well for transmitting alerts, notifications, etc. to a user to take corrective action.
    Type: Application
    Filed: May 19, 2020
    Publication date: September 3, 2020
    Inventors: Douglas William Burnette, Hari Hampapuram, Apurv Ullas Kamath, Shawn Larvenz, Aditya Mandapaka, Zebediah L. McDaniel, Tom Miller, Jeffrey R. Wedekind, Yonghuang Zeng, Stephen Alan Reichert
  • Patent number: 10687740
    Abstract: The present invention relates generally to systems and methods for processing, transmitting, and displaying data received from continuous analyte sensor, such as a glucose sensor. In some embodiments, the continuous analyte sensor system comprises a sensor electronics module that includes power saving features. One feature includes a low power measurement circuit that can be switched between a measurement mode and a low power mode, in which charging circuitry continues to apply power to electrodes of a sensor during the low power mode. In addition, the sensor electronics module can be switched between in a low power storage mode higher power operational mode via a switch. The switch can include a reed switch or optical switch, for example. A validation routine can also be implemented to ensure an interrupt signal sent from the switch is valid.
    Type: Grant
    Filed: January 28, 2019
    Date of Patent: June 23, 2020
    Assignee: DexCom, Inc.
    Inventors: Sebastian Bohm, Mark Dervaes, Eric Johnson, Apurv Ullas Kamath, Shawn Larvenz, Jacob S. Leach, Phong Lieu, Aarthi Mahalingam, Tom Miller, Paul V. Neale, Jack Pryor, Thomas A. Peyser, Daiting Rong, Kenneth San Vicente, Mohammad Ali Shariati, Peter C. Simpson, Matthew Wightlin
  • Patent number: 10519135
    Abstract: The present invention provides novel compounds of Formula (I) and Formula (II) and pharmaceutically acceptable salts, solvates, hydrates, tautomers, stereoisomers, isotopically labeled derivatives, and compositions thereof. Also provided are methods and kits involving the compounds or compositions for treating or preventing proliferative diseases (e.g., cancers (e.g., leukemia, melanoma, multiple myeloma), benign neoplasms, angiogenesis, inflammatory diseases, autoinflammatory diseases, and autoimmune diseases) in a subject. Treatment of a subject with a proliferative disease using a compound or composition of the invention may inhibit the aberrant activity of cyclin-dependent kinase 7 (CDK7), and therefore, induce cellular apoptosis and/or inhibit transcription in the subject.
    Type: Grant
    Filed: July 10, 2018
    Date of Patent: December 31, 2019
    Assignee: Syros Pharmaceuticals, Inc.
    Inventors: Kevin Sprott, Jason J. Marineau, Darby Schmidt, Michael Bradley, Stephane Ciblat, M. Arshad Siddiqui, Anzhelika Kabro, Melissa Leblanc, Serge Leger, Stephanie Roy, Dana K. Winter, Tom Miller, Amy Ripka, Dansu Li
  • Publication number: 20190350502
    Abstract: The present invention relates generally to systems and methods for processing, transmitting, and displaying data received from continuous analyte sensor, such as a glucose sensor. In some embodiments, the continuous analyte sensor system comprises a sensor electronics module that includes power saving features. One feature includes a low power measurement circuit that can be switched between a measurement mode and a low power mode, in which charging circuitry continues to apply power to electrodes of a sensor during the low power mode. In addition, the sensor electronics module can be switched between in a low power storage mode higher power operational mode via a switch. The switch can include a reed switch or optical switch, for example. A validation routine can also be implemented to ensure an interrupt signal sent from the switch is valid.
    Type: Application
    Filed: July 30, 2019
    Publication date: November 21, 2019
    Inventors: Sebastian Bohm, Mark Dervaes, Eric Johnson, Apurv Ullas Kamath, Shawn Larvenz, Jacob S. Leach, Phong Lieu, Aarthi Mahalingam, Tom Miller, Paul V. Neale, Jack Pryor, Thomas A. Peyser, Daiting Rong, Kenneth San Vicente, Mohammad Ali Shariati, Peter C. Simpson, Matthew Wightlin